Hisamitsu Pharmaceutical Co's total assets for Q4 2025 were ¥343.07B, an increase of 2.47% from the previous quarter. HTSUF total liabilities were ¥63.66B for the fiscal quarter, a -12.21% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.